XML 20 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Treasury stock at cost
Retained earnings
Accumulated other comprehensive income
Beginning balance at Dec. 31, 2019   $ 2 $ 16,126 $ (31,396) $ 17,754 $ 384
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     49      
Tax withholdings related to net share settlements of restricted stock units and awards     (83)      
Stock-based compensation     210      
Common stock repurchased     (450) (3,550)    
Other     (8)      
Net income $ 4,158       4,158  
Dividends and dividend equivalents declared         (231)  
Foreign currency translation adjustment           (64)
Change in unrealized gains (losses) on investments 1         1
Change in unrealized gains (losses) on derivative instruments           0
Tax benefit (provision) on above items           0
Ending balance at Jun. 30, 2020 $ 2,902 2 15,844 (34,946) 21,681 321
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.32          
Beginning balance at Mar. 31, 2020   2 15,723 (34,946) 21,051 285
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     45      
Tax withholdings related to net share settlements of restricted stock units and awards     (43)      
Stock-based compensation     116      
Common stock repurchased     0 0    
Other     3      
Net income $ 746       746  
Dividends and dividend equivalents declared         (116)  
Foreign currency translation adjustment           49
Change in unrealized gains (losses) on investments 32         32
Change in unrealized gains (losses) on derivative instruments           (47)
Tax benefit (provision) on above items           2
Ending balance at Jun. 30, 2020 $ 2,902 2 15,844 (34,946) 21,681 321
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.16          
Beginning balance at Dec. 31, 2020 $ 3,561 2 16,497 (36,515) 22,961 616
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     58      
Tax withholdings related to net share settlements of restricted stock units and awards     (128)      
Stock-based compensation     256      
Common stock repurchased (1,792)   0 (1,793)    
Other     (7)      
Net income 11,375       11,375  
Dividends and dividend equivalents declared         (250)  
Foreign currency translation adjustment           (107)
Change in unrealized gains (losses) on investments (4)         (4)
Change in unrealized gains (losses) on derivative instruments           70
Tax benefit (provision) on above items           (15)
Ending balance at Jun. 30, 2021 $ 13,016 2 16,676 (38,308) 34,086 560
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.36          
Beginning balance at Mar. 31, 2021   2 16,546 (36,807) 23,476 553
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     57      
Tax withholdings related to net share settlements of restricted stock units and awards     (59)      
Stock-based compensation     140      
Common stock repurchased     0 (1,501)    
Other     (8)      
Net income $ 10,734       10,734  
Dividends and dividend equivalents declared         (124)  
Foreign currency translation adjustment           10
Change in unrealized gains (losses) on investments (1)         (1)
Change in unrealized gains (losses) on derivative instruments           (4)
Tax benefit (provision) on above items           2
Ending balance at Jun. 30, 2021 $ 13,016 $ 2 $ 16,676 $ (38,308) $ 34,086 $ 560
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.18